Newsroom

JDRF, our partners and our research funding make headlines. Read about our leading role in breakthrough advances that improve lives for people with type 1 diabetes (T1D).

Recent Press Releases

JDRF Statement on the U.S. Supreme Court Affordable Care Act Ruling

June 17, 2021

Read More about JDRF Statement on the U.S. Supreme Court Affordable Care Act Ruling
Statement from JDRF Vice President of Research, Sanjoy Dutta, Ph.D., on the appointment of Kevan Herold, M.D., to TrialNet Chair

June 10, 2021

Read More about Statement from JDRF Vice President of Research, Sanjoy Dutta, Ph.D., on the appointment of Kevan Herold, M.D., to TrialNet Chair
JDRF Chair Premier Panel at 2021 Advanced Technologies & Treatments for Diabetes Conference Featuring Provention Bio, ViaCyte and vTv Therapeutics

June 2, 2021

Read More about JDRF Chair Premier Panel at 2021 Advanced Technologies & Treatments for Diabetes Conference Featuring Provention Bio, ViaCyte and vTv Therapeutics
JDRF Statement on FDA Advisory Committee Recommendation of Teplizumab

May 27, 2021

Read More about JDRF Statement on FDA Advisory Committee Recommendation of Teplizumab
JDRF Celebrates Global Accessibility Awareness Day Spotlighting Accessibility Features to JDRF.org

May 20, 2021

Read More about JDRF Celebrates Global Accessibility Awareness Day Spotlighting Accessibility Features to JDRF.org

View All

Newsroom

Recent Press Releases

JDRF Statement on the U.S. Supreme Court Affordable Care Act Ruling

Statement from JDRF Vice President of Research, Sanjoy Dutta, Ph.D., on the appointment of Kevan Herold, M.D., to TrialNet Chair

JDRF Chair Premier Panel at 2021 Advanced Technologies & Treatments for Diabetes Conference Featuring Provention Bio, ViaCyte and vTv Therapeutics

JDRF Statement on FDA Advisory Committee Recommendation of Teplizumab

JDRF Celebrates Global Accessibility Awareness Day Spotlighting Accessibility Features to JDRF.org

Your privacy